ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Melanoma and other Skin Tumours
Melanoma & Other Skin Cancers
Latest ESMO videos
Featured medwireNews
Unresectable Desmoplastic Melanoma Patients ‘Exceptional Responders’ To Pembrolizumab
IMMUNED Confirms OS Benefit For Nivolumab–Ipilimumab After Initial Stage IV Melanoma Treatment
Response To Dual ICI Therapy For Advanced Melanoma May Differ By Sex
Time Of Day At Infusion May Alter ICI Outcomes For Advanced Melanoma
Long-Term COLUMBUS Data Confirm Encorafenib–Binimetinib PFS Benefit in Advanced Melanoma
E-Learning
ESMO E-Learning: Cutaneous Squamous Cell Carcinomas (CSCC)
ESMO E-Learning: Metastatic Melanoma Treatment
Factsheets on Biomarkers
Meeting resources
Why adjuvant when there is neoadjuvant?
Presenter: Sapna Patel
Session: What’s new in 2023? (Investigational immunotherapy)
Resources:
Slides
Webcast
434MO - Increased eosinophil is a universal biomarker for immune-related adverse events induced by immune checkpoint inhibitors in various cancer patients: A retrospective multidisciplinary study
Presenter: yoshihiko tasaki
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Adjuvant treatment in high-risk stage II melanoma: Do we still need SLNB?
Presenter: Teresa Amaral
Session: Challenges in melanoma treatment
Resources:
Slides
Webcast
Advances in the management BRAF mutant melanoma
Presenter: Helen Gogas
Session: Challenges in melanoma treatment
Resources:
Slides
Webcast
Managing advanced acral and mucosal melanoma
Presenter: Karijn Suijkerbuijk
Session: Challenges in melanoma treatment
Resources:
Slides
Webcast